Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...

Ranked No. 1 in Biotech Category and No. 34 overall on World’s 50 Most Innovative Companies list The company was named No. 1 in the Biotech category and ranked No. 34 on Fast Company’s 2026 World’s 50 ...

The appointments come as eGenesis advances in clinical studies across multiple programs, including EGEN-2784 for kidney failure and a program for acute-on-chronic liver failure, positioning the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the first ever transplantation ...

Biotech company eGenesis recently announced its implanted a pig kidney into a second human patient. This animal-to-human organ transplant, or xenotransplant, was made possible through advancements in ...

“This moment—leaving the hospital today with one of the cleanest bills of health I’ve had in a long time—is one I wished would come for many years," said the patient, Richard Slayman, in a statement ...

CAMBRIDGE, Mass. and IRVINE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- eGenesis, Inc. (“eGenesis”) and Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN ...

CAMBRIDGE, Mass., June 18, 2026--eGenesis to Participate at BIO International Convention 2026 Panel on the Future of Xenotransplantation ...

Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started. Last Thursday, surgeons at ...

Please provide your email address to receive an email when new articles are posted on . A xenotransplantation program received $191 million in Series D financing to pursue a first-in-human kidney ...

CAMBRIDGE, Mass., June 22, 2026--eGenesis Appoints Glenn S. Vraniak as Chief Financial Officer and Jennifer Bergheiser as Chief Commercial Officer ...